Nivolumab/pembrolizumabVarious toxicities: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1751卷 / 1期

关键词：

D O I：

10.1007/s40278-019-61434-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：301 / 301

相关论文

共 50 条

[1] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1858 (1) : 313 - 313
[2] Nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2017, 1649 (1) : 194 - 194
[3] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1751 (1) : 221 - 221
[4] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 183 - 183
[5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1886 (1) : 240 - 240
[6] Naproxen/nivolumab/pembrolizumabVarious toxicities : 3 case reports
Reactions Weekly, 2024, 2035 (1) : 397 - 397
[7] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1710 (1) : 180 - 180
[8] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1861 (1) : 175 - 175
[9] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1697 (1) : 212 - 212
[10] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1840 (1) : 228 - 228

← 1 2 3 4 5 →